SinglArm Toripalimab Comb w/Cisplatin&Gemcitabine RecurrentMetsNasopharyngealCa SystemicTxNaiveParti
Shirin Attarian
- OPEN TO ACCRUAL
trials found matching your search:
Displaying 20 of 298 Results
study to validate a serum-based biomarkers panel to detect mucosal healing in moderate-to-severe UC
Nimisha Parekh
- OPEN TO ACCRUAL
LBP-EC01 in the Treatment of Acute Uncomplicated Urinary Tract Infection Caused by Drug Resistant Es
Carly Crowder
- OPEN TO ACCRUAL
PhI/IbVET3-TGI AdminisAlon&ComboW/PembroPtsW/AdvSolidTumor
Edward Uchio
- OPEN TO ACCRUAL
OCT RCT
Felicia Lane
- OPEN TO ACCRUAL
REBIRTH
Afshan Hameed
- OPEN TO ACCRUAL
HHS2
Judith Chung
- OPEN TO ACCRUAL
EchoTip AcuCore EUS Biopsy Needle Post-Market Study
Jason Samarasena
- OPEN TO ACCRUAL
Trial time for percutaneous nerve evaluation in patients undergoing sacral neuromodulation for urgency urinary incontinence or urgency-frequency: a randomized control trial
Charlotte Haar
- OPEN TO ACCRUAL
Paclitaxel Coated balloon for the Treatment of chronic bEnigN sTricture- Bowel
Jason Samarasena
- OPEN TO ACCRUAL
Expanded Access Use of Tecovirimat for Non-Variola Orthopoxvirus Infections
Steven Park
- OPEN TO ACCRUAL
A prospective, multicenter, single arm, open-label, feasibility study to evaluate the safety
Pengbo Jiang
- OPEN TO ACCRUAL
Evaluation of Closed Incision Negative Pressure Dressing (PREVENA) to Prevent Lower Extremity Amputa
Nii-Kabu Kabutey
- OPEN TO ACCRUAL
Evaluate Safety of a Single Intravitreal Injection of RTx-015 in Patients with Retinitis Pigmentosa
Baruch Kuppermann
- OPEN TO ACCRUAL
PhIIRandomTrialRadiotherapyW/W/OCisplatinSurgicallyResectedSquamousCellCaHead&NeckW/TP53Sequencing
Shirin Attarian
- OPEN TO ACCRUAL
INNOVATE-VSG
Ninh Tuan Nguyen
- OPEN TO ACCRUAL
A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimer
Priyanka Iyer
- OPEN TO ACCRUAL
PhIISubcAmivanComW/LazertiFirLinTxOrSubcAmivanComW/PlatBasChemoSecLinComEGFRMuLocAdvMetaNonSmaCeLuCa
Misako Nagasaka
- OPEN TO ACCRUAL
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
Anthony Chau
- OPEN TO ACCRUAL
A Phase 3, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study
Vivek R Patel
- OPEN TO ACCRUAL